NEU 3.15% $21.27 neuren pharmaceuticals limited

Pipeline-in-a-drug, page-133

  1. 858 Posts.
    lightbulb Created with Sketch. 203
    Just a question? For those that have read the contract. Is their any discussion on monetary compensation for new indications? Or is each new indication up for fresh negotiation on royalities, milestone payments, sales volume payments etc? I think people in their heads assume it would be the same model that NEU negotiated for Trof. But I presume being more cashed up and in a stronger position than Acadia these days, it would be a different negotiation this time around. My opinion only.

    I know everyone see's Acadia market cap (US2.5BN) and has opinions around Acadias ability to take over / be taken over, their assets etc but also need to look at their register and it is very impressive. If those backing Acadia want to deal, we shouldnt underestimate what they could put together potentially.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.